French Startup Secures €2.3M to Advance Cancer RNA Immunotherapy
Lyon-based biopharmaceutical company Tollys has closed a Series A funding round of €2.3M to bring…
Lyon-based biopharmaceutical company Tollys has closed a Series A funding round of €2.3M to bring…
Update (15/05/2020): The Swiss biotech ADC Therapeutics has priced its IPO on the New York…
Swedish biotech Oncopeptides has raised €133M (SEK 1.4B) by issuing new company shares, surpassing expectations…
The Swiss biotech FoRx Therapeutics has raised an impressive €10M in seed funding to develop…
The French startup Phost’in Therapeutics has raised €10.3M to take its cancer immunotherapy drug against…
Amphista Therapeutics, based in Glasgow, Scotland, is the latest company to develop drugs called PROTACs,…
The UK funder Cancer Research UK and Swedish oncology biotech Alligator Bioscience have independently announced…
An oversubscribed Series B2 round has seen the biopharmaceutical company iTeos Therapeutics raise €114M, which…
The Japanese heavyweight Ono Pharmaceutical has recruited Numab Therapeutics for a second time to co-develop…
Valo Therapeutics is operating both in the UK and Finland to develop a cancer vaccine…
The UK immunotherapy company Vaccitech has announced promising initial results from a phase IIa trial…
Austrian startup OncoOne has closed its first round of venture capital funding after raising €13M…